New liver support protocol could help patients avoid transplant
NCT ID NCT07593638
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a treatment for adults with acute-on-chronic liver failure, a sudden worsening of long-term liver disease. The approach combines blood filtering (hemoadsorption) with half-dose plasma exchange to support the liver until recovery or transplant. About 240 participants will receive either this protocol or standard care, and researchers will track survival and need for liver transplant at 28 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Unidade Hospitalar de Bragança
Bragança, Braganza District, 5301-852, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Better crystal ball for liver crisis: new scores put to the test
- Pig liver trial offers temporary lifeline for liver failure patients
- Exosome therapy shows promise for liver crisis in small trial
- New liver dialysis machine could save lives in severe liver failure
- Stem cell injection aims to prevent deadly liver complication
- Can vitamin c save kidneys in liver failure patients?